Product Name: Laforin antibody
Applications: ELISA, ICC/IF, WB
Predicted Target Size:
Positive Controls:
Form Supplied: Liquid
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Affinity chromatography purified via peptide column.
Full Name: epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
Background: This gene encodes a dual-specificity phosphatase that associates with polyribosomes. The encoded protein may be involved in the regulation of glycogen metabolism. Mutations in this gene have been associated with myoclonic epilepsy of Lafora. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Synonyms: EPM2A Antibody , MELF Antibody , EPM2 Antibody , epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) Antibody
Cellular Localization:
CAS NO: 1314890-29-3
Product: (-)-MK 801 (Maleate)
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: EPM2A antibody was raised against a 17 amino acid synthetic peptide near the carboxy terminus of human EPM2A.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: PBS containing 0.02% sodium azide.
Storage Instruction: Be stored at 4oC for three months and -20oC, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity: At least four isoforms of EPM2A are known to exist; this antibody will detect all but the shortest isoform.
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/24927566?dopt=Abstract
